Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171520-20-000226
Filing Date
2020-05-13
Accepted
2020-05-13 16:16:33
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 eps9021.htm 10-Q 330765
2 ex31-1.htm EX-31.1 9258
3 ex31-2.htm EX-31.2 9214
4 ex32.htm EX-32 3317
  Complete submission text file 0001171520-20-000226.txt   2325424

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE clpt-20200331.xml EX-101.INS 288801
6 XBRL SCHEMA FILE clpt-20200331.xsd EX-101.SCH 39125
7 XBRL CALCULATION FILE clpt-20200331_cal.xml EX-101.CAL 43890
8 XBRL DEFINITION FILE clpt-20200331_def.xml EX-101.DEF 130389
9 XBRL LABEL FILE clpt-20200331_lab.xml EX-101.LAB 300749
10 XBRL PRESENTATION FILE clpt-20200331_pre.xml EX-101.PRE 211800
Mailing Address 5 MUSICK IRVINE CA 92618
Business Address 5 MUSICK IRVINE CA 92618 9499006833
ClearPoint Neuro, Inc. (Filer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34822 | Film No.: 20873364
SIC: 3841 Surgical & Medical Instruments & Apparatus